Beverly A. Tatem
- Pharmacology top 2%
- Molecular Medicine top 1%
- Epidemiology
- Clinical Biochemistry top 5%
- Infectious Diseases top 10%
- Co-authors
- Harold C. StandifordGeorge L. DrusanoCarlos I. BustamanteStephen C. SchimpffFrank M. CaliaRichard B. HornickAlan ForrestJames Leslie
- Topics
- Antibiotics Pharmacokinetics and Efficacy (19 papers)Antibiotic Resistance in Bacteria (17 papers)Antimicrobial Resistance in Staphylococcus (7 papers)
- Journals
- Clinical Infectious DiseasesJournal of Clinical MicrobiologyAntimicrobial Agents and Chemotherapy
- Partner nations
- United States
In The Last Decade
Beverly A. Tatem
26 papers receiving 460 citations
Peers
Comparison fields: 5 of 66
- Pharmacology 399
- Molecular Medicine 299
- Epidemiology 135
- Clinical Biochemistry 133
- Infectious Diseases 127
Countries citing papers authored by Beverly A. Tatem
This map shows the geographic impact of Beverly A. Tatem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly A. Tatem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly A. Tatem more than expected).
Fields of papers citing papers by Beverly A. Tatem
This network shows the impact of papers produced by Beverly A. Tatem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly A. Tatem. The network helps show where Beverly A. Tatem may publish in the future.
Co-authorship network of co-authors of Beverly A. Tatem
This figure shows the co-authorship network connecting the top 25 collaborators of Beverly A. Tatem. A scholar is included among the top collaborators of Beverly A. Tatem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly A. Tatem. Beverly A. Tatem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 9 | |
| 3 | 21 | |
| 4 | 9 | |
| 5 | 21 | |
| 6 | 22 | |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 32 | |
| 10 | 117 | |
| 11 | 14 | |
| 12 | 3 | |
| 13 | 15 | |
| 14 | 7 | |
| 15 | 6 | |
| 16 | 1 | |
| 17 | 3 | |
| 18 | 29 | |
| 19 | 72 | |
| 20 | 12 |
About Beverly A. Tatem
Beverly A. Tatem is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 26 papers that have together received 535 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (19 papers), Antibiotic Resistance in Bacteria (17 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). The work is most often cited by research in Molecular Medicine (299 citations), Applied Microbiology and Biotechnology (81 citations) and Pharmacology (399 citations). Beverly A. Tatem has collaborated with scholars based in United States. Frequent co-authors include Harold C. Standiford, George L. Drusano, Carlos I. Bustamante, Stephen C. Schimpff, Frank M. Calia, Richard B. Hornick, Alan Forrest, James Leslie, Gaston K. Rivera and Thomas J. Walsh. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.